AspenBio Pharma, Inc. Company Profile
AspenBio Pharma, Inc. is an emerging in vitro diagnostic company focused on obtaining FDA clearance for its lead product, AppyScore, which is a unique blood-based test in development designed to help physicians manage the large number of patients who enter emergency rooms every year complaining of abdominal pain, many suspected of having acute appendicitis. As a screening test to aid in evaluating patients suspected of appendicitis based on its projected sensitivity and negative predictive value, the AppyScore test is designed to aid in identifying those patients who are at low risk for appendicitis, allowing clinicians to take a more conservative approach to patient management. The current focus of AspenBioâs effort is the use of AppyScore in children and adolescents suspicious for the disease as this population is at the highest risk of the long-term health effects associated with CT imaging. AppyScore could potentially decrease radiation exposure risk arising from the use of CT scans performed in triaging pediatric and adolescent patients with abdominal pain, as well as potentially reduce healthcare costs. The company has a large and unique repository of blood samples that provide valuable data regarding the appendicitis condition and additional protein marker information associated with causes of abdominal pain, providing an important resource for product development. For more information, visit www.aspenbiopharma.com.
News Articles
AspenBio Pharma set to market AppyScore
Denver Business Journal The headlines for AspenBio Pharma Inc. the last two years would be enough to shake just about anyone’s confidence in a company, but not that of the Castle Rock medical de...
[AspenBio] nets $11.35mm via FOPO
[AspenBio Pharma Inc.], which is currently seeking FDA approval for its {AppyScore} blood-based appendicitis test, has netted $11.35mm through a follow-on public offering of 6.1mm common shares at $2...
AspenBio Pharma to Provide Third Quarter 2012 Business Update
CASTLE ROCK, Colo., Nov.5, 2012 /PRNewswire/ --AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today announced it will provide a third quarter business update on Tuesday, Nov...
AspenBio Pharma shares rocket on company news
AspenBio Pharma Inc. soared 49 percent Thursday on a spate of news from the Castle Rock medical-device maker. (Denver Business Journal) AspenBio (Nasdaq: APPY) told investors it will begin a key clini...
AspenBio Pharma Management Discusses Q3 2012 Results - Earnings Call Transcript
AspenBio Pharma (APPY) Q3 2012 Earnings Call November 13, 2012 4:30 pm ET Executives Joshua Drumm Stephen T. Lundy - Chief Executive Officer, President and Director Donald R. Hurd - Chief Commerc...
AspenBio Announces Dismissal of Class Action and Chipman Lawsuits by U. S. District Court
CASTLE ROCK, Colo., Sept. 18, 2012 /PRNewswire/ -- AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today announced that the United States District Court for Colorado ha...
AspenBio to Present at 2012 Lazard Capital Markets Healthcare Conference
CASTLE ROCK, Colo., Nov. 13, 2012 /PRNewswire/ -- AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today announced that it will present at the 9th Annual Lazard Capital M...
AspenBio to Present at 2012 Aegis Healthcare Conference
CASTLE ROCK, Colo., Sept. 20, 2012 /PRNewswire/ -- AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today announced that it will present at the 2012 Aegis Healthcare Conferen...
Drugs and Medications
Fluoride [Libertas Pharma, Inc.]
Fluoride Chewable Tablets 0.5 mg
Fluoride [Libertas Pharma, Inc.]
Fluoride Chewable Tablets 1 mg
Metoprolol tartrate [Med-Health Pharma, LLC]
Metoprolol Tartrate Tablets, USP
Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )
PubMed Articles
Structures containing the (R)-3-amino-3-methyl piperidine unit as a new pharmacophore moiety have been shown to possess moderate inhibitory activity for DPP-4 with good pharmacokinetics profile. One o...
Is pharma running out of brainy ideas?
Clinical Trials
To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.
Pharma-Pen (Formerly Innoject) Auto-Injectory TIV
The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...
To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions
To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.
This is 2-armed parallel group, prospective, randomized, open-label, multicenter Phase 3 controlled trial to establish the efficacy and safety of conversion from maintenance immunosuppress...
Development of a New Method for Analgesia
Aim: To examine a new method to perform local anesthesia in order to diminish the inconvenience by the procedure in patients before performing intubation or oesophagogastroduodenoscopy.
Companies
AspenBio Pharma, Inc. is an emerging in vitro diagnostic company focused on obtaining FDA clearance for its lead product, AppyScore, which is a unique blood-based test in developm...
H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and...
LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...
Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies,...
AspenBio Pharma, Inc. is an emerging biotechnology company engaged in the discovery, development, manufacture, and licensing or marketing of products primarily for animal healthcare. Founded in August...
More Information about "AspenBio Pharma, Inc." on BioPortfolio
We have published hundreds of AspenBio Pharma, Inc. news stories on BioPortfolio along with dozens of AspenBio Pharma, Inc. Clinical Trials and PubMed Articles about AspenBio Pharma, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AspenBio Pharma, Inc. Companies in our database. You can also find out about relevant AspenBio Pharma, Inc. Drugs and Medications on this site too.
